Agency
Access Ohio, LLC
Access Ohio, LLC was paid $40.09M by Medicaid between Jan 2018 and Dec 2024, across 61 billing codes. Its largest line is H0011, Alcohol and/or drug services; acute detoxification (residential addiction program inpatient) — 44% of everything it billed.
33Billing provider infoACCESS OHIO, LLC
DAYTON, OH 45420
DAYTON, OH 45420
33aNPI1194179150assigned 04/15/2016
33bProvider typeCommunity/Behavioral Health Agency
28Total paid$40.09M
24GClaims384,870
24DCodes billed61
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community/Behavioral Health Agency providers in Ohio
Rank by total paid#11 of 417
Median peer was paid$469K
This provider vs. median85×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 49,844 | $3.95M | |
| 2019 | 106,490 | $5.83M | |
| 2020 | 101,495 | $5.76M | |
| 2021 | 32,431 | $6.10M | |
| 2022 | 40,233 | $8.33M | |
| 2023 | 32,415 | $5.72M | |
| 2024incomplete | 21,962 | $4.40M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H0011 | Alcohol and/or drug services; acute detoxification (residential addiction program inpatient) | 44% | 46,144 | 6,883 | $17.51M |
| H0010 | Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient) | 40% | 64,145 | 5,321 | $15.99M |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 4.0% | 13,395 | 10,500 | $1.60M |
| H0006 | Alcohol and/or drug services; case management | 2.1% | 18,473 | 6,680 | $858K |
| T1002 | Rn services, up to 15 minutes | 2.1% | 21,392 | 5,796 | $849K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | <1% | 19,848 | 2,730 | $330K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 6,964 | 5,699 | $299K |
| H0048 | Alcohol and/or other drug testing: collection and handling only, specimens other than blood | <1% | 16,385 | 12,570 | $208K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | <1% | 2,273 | 993 | $188K |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | <1% | 1,228 | 259 | $125K |
| 80347 | <1% | 5,287 | 4,130 | $99K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 2,094 | 1,986 | $92K |
49 more codes
| 80361 | <1% | 5,290 | $85K | |
| 80364 | <1% | 5,288 | $85K | |
| H2019 | Therapeutic behavioral services, billed per 15 minutes | <1% | 2,550 | $80K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | <1% | 1,523 | $78K |
| T1003 | Lpn/lvn services, up to 15 minutes | <1% | 3,953 | $76K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 659 | $76K |
| 83992 | <1% | 5,291 | $65K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,089 | $50K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,089 | $50K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 2,090 | $48K |
| 80368 | <1% | 5,291 | $47K | |
| 80373 | <1% | 5,291 | $47K | |
| 80366 | <1% | 5,291 | $47K | |
| 80357 | <1% | 5,290 | $47K | |
| 80372 | <1% | 5,290 | $47K | |
| 80338 | <1% | 5,290 | $47K | |
| 80339 | <1% | 5,289 | $47K | |
| 80355 | <1% | 5,290 | $47K | |
| 80349 | <1% | 5,291 | $47K | |
| 80334 | <1% | 5,288 | $47K | |
| 80365 | <1% | 5,291 | $47K | |
| 80358 | <1% | 5,290 | $47K | |
| 80353 | <1% | 5,290 | $47K | |
| 80359 | <1% | 5,290 | $47K | |
| 80348 | <1% | 5,290 | $47K | |
| 80354 | <1% | 5,290 | $47K | |
| 80324 | <1% | 5,289 | $47K | |
| 80360 | <1% | 5,289 | $47K | |
| 80345 | <1% | 5,288 | $47K | |
| 80356 | <1% | 5,288 | $47K | |
| 80371 | <1% | 5,288 | $47K | |
| 80337 | <1% | 5,286 | $47K | |
| 80323 | <1% | 5,288 | $45K | |
| 80367 | <1% | 3,972 | $35K | |
| 80369 | <1% | 3,971 | $35K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 161 | $26K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 220 | $13K |
| 86780 | <1% | 1,844 | $13K | |
| 80370 | <1% | 1,311 | $12K | |
| 80344 | <1% | 1,311 | $12K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 58 | $6K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 109 | $5K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 87 | $4K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 43 | $2K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 26 | $1K |
| H0036 | Community psychiatric support and treatment, per 15 minutes | <1% | 1,544 | $937.92 |
| 81226 | <1% | 19 | $204.33 | |
| 81225 | <1% | 19 | $132.03 | |
| H0016 | Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) | 0% | 67 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSON, JOHN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Access Ohio, LLC | Columbus, OH | $72.55M |
| Johnson City Eye Clinic PC | Johnson City, TN | $2.28M |
| Access Behavioral LLC | Columbus, OH | $935K |
| Access Hospital Dayton LLC | Dayton, OH | $555K |
| Greater Boston Allergy Asthma Sinus & Immunology Centers, P.C. | Hyannis, MA | $453K |
| Malabar Anesthesia Services INC | Mansfield, OH | $114K |
| Deep South Chiropractic Clinic | Leesville, LA | $32K |
| Batesville Medical Specialties LLC | Batesville, IN | $13K |
| Aberdeen Ventures, LTD. | Crown Point, IN | $10K |
| Clinton Highland Joint Fire | New Vienna, OH | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.